Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pratik Pal, Peiyi Zhang, Saikat K. Poddar & Guangrong Zheng. (2022) Patent landscape of inhibitors and PROTACs of the anti-apoptotic BCL-2 family proteins. Expert Opinion on Therapeutic Patents 32:9, pages 1003-1026.
Read now
Read now
Kui Li & Hongqi Tian. (2019) Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new
therapeutic strategy for tumour immunotherapy. Journal of Drug Targeting 27:3, pages 244-256.
Read now
Read now
Kayode Ezekiel Adewole & Ahmed Adebayo Ishola. (2019) Phytosterols and triterpenes from Morinda lucida Benth (Rubiaceae) as potential inhibitors of anti-apoptotic BCL-XL, BCL-2, and MCL-1: an in-silico study. Journal of Receptors and Signal Transduction 39:1, pages 87-97.
Read now
Read now
Lijia Chen & Steven Fletcher. (2017) Mcl-1 inhibitors: a patent review. Expert Opinion on Therapeutic Patents 27:2, pages 163-178.
Read now
Read now
Xavier Thomas & Caroline Le Jeune. (2016) The safety of treatment options for elderly people with acute myeloid leukemia. Expert Opinion on Drug Safety 15:5, pages 635-645.
Read now
Read now
Articles from other publishers (69)
Qineng Gong, Haojie Wang, Mi Zhou, Lu Zhou, Renxiao Wang & Yan Li. (2023) B‐cell lymphoma‐2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy. Medicinal Research Reviews.
Crossref
Crossref
Fatemeh Mehraban, Fariba Heidari Esfahani, Zahra Mosayebi Dorcheh, Erfaneh Heidari Esfahani, Mansoureh Azadeh & Ali Salehzadeh. (2023) Evaluation of the cytotoxic effect of GaFe2O4@Ag magnetic nanocomposite biosynthesized by Spirulina platensis on breast cancer cell line and evaluation of BAX, Bcl-2, CASP9 and MMP1 genes expression. Inorganic Chemistry Communications 157, pages 111307.
Crossref
Crossref
Vincent Mallet, Luis Checa Ruano, Alexandra Moine Franel, Michael Nilges, Karen Druart, Guillaume Bouvier & Olivier Sperandio. (2022)
InDeep: 3D fully convolutional neural networks to assist
in silico
drug design on protein–protein interactions
. Bioinformatics 38:5, pages 1261-1268.
Crossref
Crossref
Mogammad Baaghith Hamid, Antonio Mendes Serafin & John Mbabuni Akudugu. (2021) Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells. European Journal of Pharmacology 912, pages 174612.
Crossref
Crossref
Karunaithas Rasaratnam, Chanin Nantasenamat, Narumon Phaonakrop, Sittiruk Roytrakul & Dalina Tanyong. (2021) A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl‐2 family proteins. Chemical Biology & Drug Design 97:5, pages 1017-1028.
Crossref
Crossref
Kexue Li. (2021) Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology. Bioorganic & Medicinal Chemistry Letters 32, pages 127717.
Crossref
Crossref
Liqun Sun, Meihua Sun, Ke Ma & Jiangtao Liu. (2020) Let-7d-5p suppresses inflammatory response in neonatal rats with necrotizing enterocolitis via LGALS3-mediated TLR4/NF-κB signaling pathway. American Journal of Physiology-Cell Physiology 319:6, pages C967-C979.
Crossref
Crossref
Aline Lagoeiro do Carmo, Fernanda Bettanin, Michell Oliveira Almeida, Simone Queiroz Pantaleão, Tiago Rodrigues, Paula Homem-de-Mello & Kathia Maria Honorio. (2020) Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein. Frontiers in Chemistry 8.
Crossref
Crossref
Chiara Modica, Simona Gallo, Cristina Chiriaco, Martina Spilinga, Paolo Maria Comoglio, Tiziana Crepaldi, Cristina Basilico & Elisa Vigna. (2020) Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody. Cancers 12:3, pages 741.
Crossref
Crossref
Zheyi Zhou, Changjun Lu, Shuhui Meng, Linglu Dun, Nannan Yin, Hongwei An, Hong Xu, Guocheng Liu & Yefeng Cai. (2019) Silencing of PTGS2 exerts promoting effects on angiogenesis endothelial progenitor cells in mice with ischemic stroke via repression of the NF‐κB signaling pathway. Journal of Cellular Physiology 234:12, pages 23448-23460.
Crossref
Crossref
Joan Montero, Cécile Gstalder, Daniel J. Kim, Dorota Sadowicz, Wayne Miles, Michael Manos, Justin R. Cidado, J. Paul Secrist, Adriana E. Tron, Keith Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher & Rizwan Haq. (2019) Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies. Nature Communications 10:1.
Crossref
Crossref
Vasanti Suvarna, Vikas Singh & Manikanta Murahari. (2019) Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy. European Journal of Pharmacology 862, pages 172655.
Crossref
Crossref
Aarti Anantram & Mariam Degani. (2019) Targeting cancer's Achilles’ heel: role of BCL-2 inhibitors in cellular senescence and apoptosis. Future Medicinal Chemistry 11:17, pages 2287-2312.
Crossref
Crossref
Julie A. Preston, Martin A. Bewley, Helen M. Marriott, A. McGarry Houghton, Mohammed Mohasin, Jamil Jubrail, Lucy Morris, Yvonne L. Stephenson, Simon Cross, David R. Greaves, Ruth W. Craig, Nico van Rooijen, Colin D. Bingle, Robert C. Read, Timothy J. Mitchell, Moira K. B. Whyte, Steven D. Shapiro & David H. Dockrell. (2019) Alveolar Macrophage Apoptosis–associated Bacterial Killing Helps Prevent Murine Pneumonia. American Journal of Respiratory and Critical Care Medicine 200:1, pages 84-97.
Crossref
Crossref
Dina S. El-Kady, Ahmed A. Abd Rabou, Mohamed A. Tantawy, Adel A.-H. Abdel-Rahman, Amira A.-S. Abdel-Megeed, Mervat M. AbdElhalim & Gamal A. Elmegeed. (2019) Synthesis and Evaluation of Novel Cholestanoheterocyclic Steroids as Anticancer Agents. Applied Biochemistry and Biotechnology 188:3, pages 635-662.
Crossref
Crossref
Keisuke Sekiya, Tasuku Nishihara, Naoki Abe, Amane Konishi, Hideyuki Nandate, Taisuke Hamada, Keizo Ikemune, Yasushi Takasaki, Junya Tanaka, Migiwa Asano & Toshihiro Yorozuya. (2019) Carbon monoxide poisoning–induced delayed encephalopathy accompanies decreased microglial cell numbers: Distinctive pathophysiological features from hypoxemia–induced brain damage. Brain Research 1710, pages 22-32.
Crossref
Crossref
Nianzhe He, Peng Liu, Ziqian Wang, Zongwei Guo, Xinxin Yan, Hongbo Chen & Zhichao Zhang. (2019) Discovery of selective Mcl-1 inhibitors via structure-based design and structure-activity relationship analysis. Biochemical and Biophysical Research Communications 512:4, pages 921-926.
Crossref
Crossref
Eram Shakeel, Rajnish Kumar, Neha Sharma, Salman Akhtar, Mohd. Kalim Ahmad Khan, Mohtashim Lohani & Mohd. Haris Siddiqui. (2019) Computational Outlook of Marine Compounds as Anti-Cancer Representatives Targeting BCL-2 and Survivin. Current Computer-Aided Drug Design 15:3, pages 265-276.
Crossref
Crossref
Su‐Xia Ma, Zhi‐Feng Bai, Wei Wang & Hui‐Ying Wu. (2017)
Retracted
: Effects of microrna‐93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF‐ΚB pathway
. Journal of Cellular Biochemistry 120:3, pages 2847-2858.
Crossref
Crossref
Eram Shakeel, Neha Sharma, Salman Akhtar, Mohd. Kalim Ahmad Khan, Mohtashim Lohani & Mohd. Haris Siddiqui. (2018) Decoding the antineoplastic efficacy of Aplysin targeting Bcl-2: A de novo perspective. Computational Biology and Chemistry 77, pages 390-401.
Crossref
Crossref
Ahmed S. A. Mady, Chenzhong Liao, Naval Bajwa, Karson J. Kump, Fardokht A. Abulwerdi, Katherine L. Lev, Lei Miao, Sierrah M. Grigsby, Andrej Perdih, Jeanne A. Stuckey, Yuhong Du, Haian Fu & Zaneta Nikolovska-Coleska. (2018) Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening. Scientific Reports 8:1.
Crossref
Crossref
Muhammad Zafar, Iqra Sarfraz, Azhar Rasul, Faiza Jabeen, Khizar Samiullah, Ghulam Hussain, Ammara Riaz & Muhammad Ali. (2018) Tubeimoside-1, Triterpenoid Saponin, as a Potential Natural Cancer Killer. Natural Product Communications 13:5, pages 1934578X1801300.
Crossref
Crossref
Zhengrong Zhu, Alex Shaginian, LaShadric C. Grady, Thomas O’Keeffe, Xiangguo E. Shi, Christopher P. Davie, Graham L. Simpson, Jeffrey A. Messer, Ghotas Evindar, Robert N. Bream, Praew P. Thansandote, Naomi R. Prentice, Andrew M. Mason & Sandeep Pal. (2017) Design and Application of a DNA-Encoded Macrocyclic Peptide Library. ACS Chemical Biology 13:1, pages 53-59.
Crossref
Crossref
Mohamad Norisham Mohamad Rosdi, Shahkila Mohd Arif, Mohamad Hafizi Abu Bakar, Siti Aisyah Razali, Razauden Mohamed Zulkifli & Harisun Ya’akob. (2017) Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins. Apoptosis 23:1, pages 27-40.
Crossref
Crossref
Yao Adzavon, Pengxiang Zhao, Xin Zhang, Mengyu Liu, Baobei Lv, Linqi Yang, Xujuan Zhang, Fei Xie, Mingzi Zhang, Jianmin Ma & Xuemei Ma. (2017) Genes and pathways associated with the occurrence of malignancy in benign lymphoepithelial lesions. Molecular Medicine Reports.
Crossref
Crossref
Ruth Rodriguez-Barrueco, Erin A. Nekritz, François Bertucci, Jiyang Yu, Felix Sanchez-Garcia, Tizita Z. Zeleke, Andrej Gorbatenko, Daniel Birnbaum, Elena Ezhkova, Carlos Cordon-Cardo, Pascal Finetti, David Llobet-Navas & Jose M. Silva. (2017) miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy. Genes & Development 31:6, pages 553-566.
Crossref
Crossref
Abhishek A. Singh, Amit Mandoli, Koen H.M. Prange, Marko Laakso & Joost H.A. Martens. (2016) AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis. Oncotarget 8:8, pages 12855-12865.
Crossref
Crossref
Xavier Thomas & Caroline Le Jeune. (2017) Treatment of Elderly Patients With Acute Myeloid Leukemia. Current Treatment Options in Oncology 18:1.
Crossref
Crossref
Stanley R. Frankel & Dow-Chung Chi. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets
833
850
.
Dingyi Yang, Xiaochuan Zou, Ruokun Yi, Weiwei Liu, Deguang Peng & Xin Zhao. (2016) Neferine increase in vitro anticancer effect of dehydroepiandrosterone on MCF-7 human breast cancer cells. Applied Biological Chemistry 59:4, pages 585-596.
Crossref
Crossref
Mei-Miao Zhan, Xue-Qin Hu, Xiu-Xiu Liu, Ban-Feng Ruan, Jun Xu & Chenzhong Liao. (2016) From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway. Drug Discovery Today 21:6, pages 1027-1036.
Crossref
Crossref
Jorge J. Castillo, Zachary R. Hunter, Guang Yang, Kimon Argyropoulos, M. Lia Palomba & Steven P. Treon. (2016) Future therapeutic options for patients with Waldenström macroglobulinemia. Best Practice & Research Clinical Haematology 29:2, pages 206-215.
Crossref
Crossref
Ragul Gowthaman, Sven A. Miller, Steven Rogers, Jittasak Khowsathit, Lan Lan, Nan Bai, David K. Johnson, Chunjing Liu, Liang Xu, Asokan Anbanandam, Jeffrey Aubé, Anuradha Roy & John Karanicolas. (2015) DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites. Journal of Medicinal Chemistry 59:9, pages 4152-4170.
Crossref
Crossref
Wei Dai, Quangen Gao, Jianping Qiu, Jianmao Yuan, Guoliang Wu & Genhai Shen. (2015) Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. Tumor Biology 37:5, pages 6307-6313.
Crossref
Crossref
Diego F.M. Mühlbeier, Vera A. Saddi, Élbio C. de Paula, Isabela W. Cunha, José H.T.G. Fregnani, Maria A. Barbosa & Wilmar J. Manoel. (2016) Prognostic Significance of Apoptosis-related Markers in Patients With Soft-Tissue Sarcomas of Extremities. Applied Immunohistochemistry & Molecular Morphology 24:4, pages 268-274.
Crossref
Crossref
Sandra Söderholm, Maria Anastasina, Mohammad Majharul Islam, Janne Tynell, Minna M. Poranen, Dennis H. Bamford, Jakob Stenman, Ilkka Julkunen, Ingrida Šaulienė, Jef K. De Brabander, Sampsa Matikainen, Tuula A. Nyman, Xavier Saelens & Denis Kainov. (2016) Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine. Antiviral Research 126, pages 69-80.
Crossref
Crossref
Duong Nhu, Guillaume Lessene, David C. S. Huang & Christopher J. Burns. (2016) Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy. MedChemComm 7:5, pages 778-787.
Crossref
Crossref
Martina Broecker-Preuss, Jan Viehof, Holger Jastrow, Nina Becher-Boveleth, Dagmar Fuhrer & Klaus Mann. (2015) Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Nevine M.Y. Elsayed, Dalal A. Abou El Ella, Rabah A.T. Serya & Khaled A.M. Abouzid. (2015) Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents. Future Journal of Pharmaceutical Sciences 1:1, pages 16-21.
Crossref
Crossref
Obaid Afzal, Suresh Kumar, Md Rafi Haider, Md Rahmat Ali, Rajiv Kumar, Manu Jaggi & Sandhya Bawa. (2015) A review on anticancer potential of bioactive heterocycle quinoline. European Journal of Medicinal Chemistry 97, pages 871-910.
Crossref
Crossref
Samaher Besbes, Massoud Mirshahi, Marc Pocard & Christian Billard. (2015) New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget 6:15, pages 12862-12871.
Crossref
Crossref
Omar Niss, Allyson Sholl, Jack J. Bleesing & David A. Hildeman. (2015) IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome. Journal of Allergy and Clinical Immunology 135:3, pages 762-770.
Crossref
Crossref
Sandy Desrat, Camille Remeur & Fanny Roussi. (2015) Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins. Organic & Biomolecular Chemistry 13:19, pages 5520-5531.
Crossref
Crossref
Evangeline Drink, Philippe Dugourd, Elise Dumont, Nils Aronssohn, Rodolphe Antoine & Claire Loison. (2015) Optical properties of prodigiosin and obatoclax: action spectroscopy and theoretical calculations. Physical Chemistry Chemical Physics 17:39, pages 25946-25955.
Crossref
Crossref
Johannes Belmar & Stephen W. Fesik. (2015) Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacology & Therapeutics 145, pages 76-84.
Crossref
Crossref
Bin Wang, Linfeng Chen, Zhenhong Ni, Xufang Dai, Liyan Qin, Yaran Wu, Xinzhe Li, Liang Xu, Jiqin Lian & Fengtian He. (2014) Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells. Experimental Cell Research 328:2, pages 379-387.
Crossref
Crossref
Sandy Desrat, Anaïs Pujals, Claire Colas, Jérémy Dardenne, Charlotte Gény, Loëtitia Favre, Vincent Dumontet, Bogdan I. Iorga, Marc Litaudon, Martine Raphaël, Joëlle Wiels & Fanny Roussi. (2014) Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1. Bioorganic & Medicinal Chemistry Letters 24:21, pages 5086-5088.
Crossref
Crossref
Claudia Cerella, Marie-Hélène Teiten, Flavia Radogna, Mario Dicato & Marc Diederich. (2014) From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnology Advances 32:6, pages 1111-1122.
Crossref
Crossref
Fardokht A. Abulwerdi, Chenzhong Liao, Ahmed S. Mady, Jordan Gavin, Chenxi Shen, Tomasz Cierpicki, Jeanne A. Stuckey, H. D. Hollis Showalter & Zaneta Nikolovska-Coleska. (2014)
3-Substituted-
N
-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation
. Journal of Medicinal Chemistry 57:10, pages 4111-4133.
Crossref
Crossref
Tracy L. Nero, Craig J. Morton, Jessica K. Holien, Jerome Wielens & Michael W. Parker. (2014) Oncogenic protein interfaces: small molecules, big challenges. Nature Reviews Cancer 14:4, pages 248-262.
Crossref
Crossref
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, Asfar S. Azmi, Amro Aboukameel, Ahmed S.A. Mady, Thippeswamy Gulappa, Tomasz Cierpicki, Scott Owens, Tao Zhang, Duxin Sun, Jeanne A. Stuckey, Ramzi M. Mohammad & Zaneta Nikolovska-Coleska. (2014)
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth
In Vitro
and
In Vivo
. Molecular Cancer Therapeutics 13:3, pages 565-575.
Crossref
Crossref
Mohammad S. Jamal, Shadma Parveen, Mohd A. Beg, Mohd Suhail, Adeel G. A. Chaudhary, Ghazi A. Damanhouri, Adel M. Abuzenadah & Mohd Rehan. (2014) Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches. PLoS ONE 9:2, pages e87309.
Crossref
Crossref
S. Desrat, C. Remeur, C. Gény, G. Rivière, C. Colas, V. Dumontet, N. Birlirakis, B. I. Iorga & F. Roussi. (2014) From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins. Chemical Communications 50:62, pages 8593.
Crossref
Crossref
Yuta Tanaka, Katsuji Aikawa, Goushi Nishida, Misaki Homma, Satoshi Sogabe, Shigeru Igaki, Yumi Hayano, Tomoya Sameshima, Ikuo Miyahisa, Tomohiro Kawamoto, Michiko Tawada, Yumi Imai, Masakazu Inazuka, Nobuo Cho, Yasuhiro Imaeda & Tomoyasu Ishikawa. (2013) Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins. Journal of Medicinal Chemistry 56:23, pages 9635-9645.
Crossref
Crossref
Le Yu & Shuwen Liu. (2013) Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Seminars in Cancer Biology 23:6, pages 553-560.
Crossref
Crossref
Christian Billard. (2013) BH3 Mimetics: Status of the Field and New Developments. Molecular Cancer Therapeutics 12:9, pages 1691-1700.
Crossref
Crossref
Ruizan Shi, Hongwei Peng, Xiangfei Yuan, Xiuli Zhang, Yanjun Zhang, Dongmei Fan, Xuyi Liu & Dongsheng Xiong. (2013) Down‐regulation of c‐fos by shRNA sensitizes adriamycin‐resistant MCF‐7/ADR cells to chemotherapeutic agents via P‐glycoprotein inhibition and apoptosis augmentation. Journal of Cellular Biochemistry 114:8, pages 1890-1900.
Crossref
Crossref
Sara Samuel, Vladimir Beljanski, Julien Van Grevenynghe, Stephanie Richards, Fethia Ben Yebdri, Zhong He, Carmen Nichols, S Mehdi Belgnaoui, Courtney Steel, Marie-Line Goulet, April Shamy, Dawn Brown, Guillermo Abesada, Elias K Haddad & John Hiscott. (2013) BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis. Molecular Therapy 21:7, pages 1413-1423.
Crossref
Crossref
M Karaayvaz, H Zhai & J Ju. (2013) miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death & Disease 4:6, pages e659-e659.
Crossref
Crossref
Teresa Marafioti, Christiane Copie‐Bergman, Maria Calaminici, Jennifer C Paterson, Vishvesh H Shende, Hongxiang Liu, Maryse Baia, Alan D Ramsay, Claudio Agostinelli, Josette Brière, Andrew Clear, Ming‐Qing Du, Pier Paolo Piccaluga, Noraidah Masir, Elizabeth P Nacheva, Pierre Sujobert, Kandavel Shanmugam, Thomas M Grogan, Simon P Brooks, Asim Khwaja, Kirit Ardeshna, William Townsend, Stefano A Pileri, Corinne Haioun, David Linch, John G Gribben, Philippe Gaulard & Peter G Isaacson. (2013) Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups. Histopathology 62:6, pages 860-875.
Crossref
Crossref
Rania Hamdy, Noha Ziedan, Samia Ali, Mohamed El-Sadek, Elsaid Lashin, Andrea Brancale, Arwyn T. Jones & Andrew D. Westwell. (2013) Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents. Bioorganic & Medicinal Chemistry Letters 23:8, pages 2391-2394.
Crossref
Crossref
Hee Nam Lim & Kathlyn A. Parker. (2012) Total Synthesis of Kingianin A. Organic Letters 15:2, pages 398-401.
Crossref
Crossref
Stanley R Frankel & Dow-Chung Chi. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
18
.
Sofia Caria, Srishti Chugh, Duong Nhu, Guillaume Lessene & Marc Kvansakul. (2012) Crystallization and preliminary X-ray characterization of Epstein–Barr virus BHRF1 in complex with a benzoylurea peptidomimetic. Acta Crystallographica Section F Structural Biology and Crystallization Communications 68:12, pages 1521-1524.
Crossref
Crossref
Emmanuelle Saugues, Anne-Laure Debaud, Fabrice Anizon, Nathalie Bonnefoy & Pascale Moreau. (2012) Synthesis and biological activities of polyquinoline derivatives: New Bcl-2 family protein modulators. European Journal of Medicinal Chemistry 57, pages 112-125.
Crossref
Crossref
Oxana V. Denisova, Laura Kakkola, Lin Feng, Jakob Stenman, Ashwini Nagaraj, Johanna Lampe, Bhagwan Yadav, Tero Aittokallio, Pasi Kaukinen, Tero Ahola, Suvi Kuivanen, Olli Vapalahti, Anu Kantele, Janne Tynell, Ilkka Julkunen, Hannimari Kallio-Kokko, Henrik Paavilainen, Veijo Hukkanen, Richard M. Elliott, Jef K. De Brabander, Xavier Saelens & Denis E. Kainov. (2012) Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection. Journal of Biological Chemistry 287:42, pages 35324-35332.
Crossref
Crossref
Irina Milisav, Borut Poljsak & Dušan Šuput. (2012) Adaptive Response, Evidence of Cross-Resistance and Its Potential Clinical Use. International Journal of Molecular Sciences 13:9, pages 10771-10806.
Crossref
Crossref
Laura Delgado-Soler, Marta Pinto, Kaori Tanaka-Gil & Jaime Rubio-Martinez. (2012) Molecular Determinants of Bim(BH3) Peptide Binding to Pro-Survival Proteins. Journal of Chemical Information and Modeling 52:8, pages 2107-2118.
Crossref
Crossref
Sean P. Brown & Joshua P. Taygerly. 2012. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry Volume 47
253
266
.